Loading clinical trials...

LUXSOL(TM) Topical Cream for the Treatment of Symptomatic Bacterial Vaginosis; A Proof of Concept Study | Clinical Trials | Clareo Health

Back to clinical trial search

TERMINATEDEARLY Phase 1NCT02197182

LUXSOL(TM) Topical Cream for the Treatment of Symptomatic Bacterial Vaginosis; A Proof of Concept Study

LUXSOL Cream may be useful for the treatment of bacterial Vaginosis. In this study, LUXSOL Cream is compared to a control arm group using metronidazole cream. LUXSOL is administered intravaginally for...

Lead sponsor: CDA Research Group, Inc.•2 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGNA

An Open Single-armed Investigation to Evaluate the Safety of pHyph Following a Prolonged Treatment Duration in Adult Women With Bacterial Vaginosis

NCT07394777 · Bacterial Vaginosis (BV)

COMPLETEDPhase 2

Dose-ranging Study of SPL7013 Gel for the Prevention of Bacterial Vaginosis (BV)

NCT01437722 · Recurrent Bacterial Vaginosis (BV)

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 5, 2018Terms

Trial snapshot

StatusTERMINATED

PhaseEARLY_PHASE1

Enrollment50

Start dateJun 2014

Last updatedApr 5, 2018

Condition

Bacterial Vaginosis (BV)

Locations shown

Harper University Hospital Department of Infectious Diseases

Detroit, Michigan

Temple University Hospital Department of OB/GYN

Philadelphia, Pennsylvania

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 5, 2018Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions